VSee Health Valuation

Is VSEE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VSEE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VSEE ($1.16) is trading below our estimate of fair value ($1.72)

Significantly Below Fair Value: VSEE is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for VSEE?

Other financial metrics that can be useful for relative valuation.

VSEE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.3x
Enterprise Value/EBITDA-23.2x
PEG Ration/a

Price to Sales Ratio vs Peers

How does VSEE's PS Ratio compare to its peers?

The above table shows the PS ratio for VSEE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average9.2x
DRIO DarioHealth
1.3x31.1%US$24.3m
CRVW CareView Communications
3.3xn/aUS$29.8m
HLYK HealthLynked
3.5xn/aUS$14.7m
ONMD OneMedNet
28.7xn/aUS$31.1m
VSEE VSee Health
3xn/aUS$19.2m

Price-To-Sales vs Peers: VSEE is good value based on its Price-To-Sales Ratio (3x) compared to the peer average (9.2x).


Price to Earnings Ratio vs Industry

How does VSEE's PE Ratio compare vs other companies in the US Healthcare Services Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a30.9%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a30.9%
n/an/an/a
No more companies

Price-To-Sales vs Industry: VSEE is expensive based on its Price-To-Sales Ratio (3x) compared to the US Healthcare Services industry average (2.1x).


Price to Sales Ratio vs Fair Ratio

What is VSEE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VSEE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate VSEE's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies